114322-14-4 Usage
Description
2,1,3-Benzoxadiazole-4-sulfonyl chloride is a chemical compound characterized by its molecular formula, C6H2ClN2O3S. It is a reagent in organic synthesis, featuring heterocyclic and sulfonyl elements. Known for its reactivity with water, it forms sulfonic acid and hydrochloric acid upon reaction. Due to its reactive nature, it requires careful handling and is typically stored in a cool, dry place. It is commonly used in laboratory settings.
Uses
Used in Organic Synthesis:
2,1,3-Benzoxadiazole-4-sulfonyl chloride is used as a reagent in organic synthesis for its ability to form various chemical compounds. Its unique structure and reactivity make it a valuable component in the creation of new organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,1,3-benzoxadiazole-4-sulfonyl chloride is used as a building block for the synthesis of drug candidates. Its versatile chemical properties allow for the development of novel therapeutic agents with potential applications in treating various diseases.
Used in Chemical Research:
2,1,3-Benzoxadiazole-4-sulfonyl chloride is used as a research tool in chemical laboratories. Its reactivity and unique structure make it an interesting subject for studying chemical reactions and exploring new synthetic pathways.
Used in Material Science:
In the field of material science, 2,1,3-benzoxadiazole-4-sulfonyl chloride is used as a precursor for the development of new materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with enhanced characteristics, such as improved stability or reactivity.
Overall, 2,1,3-benzoxadiazole-4-sulfonyl chloride is a versatile chemical compound with applications in various industries, including organic synthesis, pharmaceuticals, chemical research, and material science. Its unique properties and reactivity make it a valuable asset in the development of new compounds and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 114322-14-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,4,3,2 and 2 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 114322-14:
(8*1)+(7*1)+(6*4)+(5*3)+(4*2)+(3*2)+(2*1)+(1*4)=74
74 % 10 = 4
So 114322-14-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H3ClN2O3S/c7-13(10,11)5-3-1-2-4-6(5)9-12-8-4/h1-3H
114322-14-4Relevant articles and documents
A convenient synthesis of novel 3-(heterocyclylsulfonyl)propanoic acids and their amide derivatives
Dorogov, Mikhail V.,Filimonov, Sergey I.,Kobylinsky, Dmitry B.,Ivanovsky, Sergey A.,Korikov, Pavel V.,Soloviev, Mikhail Y.,Khahina, Maria Y.,Shalygina, Elena E.,Kravchenko, Dmitry V.,Ivachtchenko, Alexandre V.
, p. 2999 - 3004 (2007/10/03)
A large number of novel 3-(heterocyclylsulfonyl)propanoic acids and their amide derivatives were prepared in good yields and excellent purity starting from the corresponding heterocyclic compounds. At first, chlorosulfonates were generated by reaction of initial heterocycles with various sulfonating and chlorinating agents followed by their conversion into sodium sulfinates. Treatment of sulfinates with acrylic acid smoothly afforded a series of sulfonylpropionates, which were used as convenient reagents for the preparation of a large number of the corresponding carboxamide derivatives.
SULFONAMIDE INHIBITORS OF ASPARTYL PROTEASE
-
, (2010/12/01)
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.
